|
Market Closed -
Saudi Arabian S.E.
13:20:00 01/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 62.20 SAR | -1.50% |
|
-3.12% | -2.11% |
| 09-17 | Avalon Pharma Renews SAR104 Million Bank Facility Deal with Banque Saudi Fransi | MT |
| 08-27 | Avalon Pharma Reiterated at Overweight as Aljazira Capital Notes 'Solid' Q2 Growth | MT |
Stock exchange
Saudi Arabian S.E.
4016 62.20 ﷼
-1.50%
2.56M
﷼
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| 4016 | 62.20SAR | -1.50% | 2.56M ﷼ |
Quotes 5-day view: Middle East Pharmaceutical Industries Company
Delayed Quote Saudi Arabian S.E.
| 27/09/2026 | 28/09/2026 | 29/09/2026 | 30/09/2026 | 01/10/2026 | |
|---|---|---|---|---|---|
| Last | SAR 63.90 | SAR 63.70 | SAR 63.20 | SAR 63.15 | SAR 62.20 |
| Volume | 17,094 | 64,728 | 84,153 | 56,709 | 41,141 |
| Change | -0.47% | -0.31% | -0.78% | -0.08% | -1.50% |
| Opening | SAR 63.85 | SAR 64.50 | SAR 63.75 | SAR 63.20 | SAR 63.10 |
| High | SAR 64.40 | SAR 64.50 | SAR 64.05 | SAR 64.55 | SAR 63.30 |
| Low | SAR 63.70 | SAR 63.45 | SAR 63.05 | SAR 63.00 | SAR 61.90 |
Performance
| 1 day | -1.50% | ||
| 1 week | -3.12% | ||
| Current month | -1.50% | ||
| 1 month | -6.75% | ||
| 3 months | +1.88% | ||
| 6 months | +11.36% | ||
| Current year | -2.11% | ||
| 1 year | -15.23% |
Volumes
marketsDaily volume
41,141
Estimated daily volume
41,141
Avg. Volume 20 sessions
57,025
Daily volume ratio
0.72
Avg. Volume 20 sessions SAR
3,546,955
Avg. Volume 20 sessions USD
944,795.31
Record volume 1
7,299,233
Record volume 2
4,505,032
Record volume 3
3,303,143
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (SAR)
2,176,999,999
Market Cap (USD)
579,837,528
Net sales (SAR)
460,484,823
Net sales (USD)
122,648,774
Number of employees
731
Sales / Employee (SAR)
629,938
Sales / Employee (USD)
167,782
Free-Float
46.88%
Free-Float capitalization (SAR)
1,020,468,749
Free-Float capitalization (USD)
271,798,841
Average Daily Capital Traded
0.16%
Indicators
Moving average 5 days
63.23
Moving average 20 days
65.31
Moving average 50 days
62.64
Moving average 100 days
61.47
Price spread / (MMA5)
+1.66%
Price spread / (MMA20)
+5.00%
Price spread / (MMA50)
+0.70%
Price spread / (MMA100)
-1.17%
RSI 9 days
37.79
RSI 14 days
44.17
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.50% | -3.12% | -15.23% | - | 580M | |
| -0.61% | -3.43% | +39.40% | +112.31% | 1,019B | |
| -1.02% | -5.60% | +37.67% | +65.02% | 617B | |
| +1.11% | -0.58% | +11.10% | +77.28% | 464B | |
| +0.34% | -3.01% | +61.21% | +40.71% | 356B | |
| -0.95% | -4.05% | +21.60% | +39.37% | 333B | |
| -1.46% | -2.89% | +11.84% | +24.60% | 267B | |
| -1.35% | -5.43% | -4.69% | +8.40% | 244B | |
| -1.04% | -2.79% | +35.52% | +51.34% | 218B | |
| -1.87% | -4.10% | +30.92% | +95.33% | 179B | |
| Average | -0.36% | -3.36% | +22.93% | +57.15% | 369.78B | |
| Weighted average by Cap. | +0.42% | -3.33% | +30.51% | +68.96% |
Historical Quotes: Middle East Pharmaceutical Industries Company
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
381c.4zU33BwGNir1mSxpnHbGqs3U74ACPiHR0dVpawCehbg.jHdHkWpqBX2FzEkM10_1z6aS2td0X2q8srwFJ3Dst_y2B1ivV1wAGKfVTw
| Date | Price | Volume | Total |
|---|---|---|---|
| 12:44:32 | 62.25 | 5 | 38,295 |
| 12:41:13 | 62.20 | 71 | 38,290 |
| 12:41:13 | 62.20 | 57 | 38,219 |
| 12:41:13 | 62.20 | 31 | 38,162 |
| 12:41:13 | 62.20 | 4 | 38,131 |
| 12:41:13 | 62.20 | 37 | 38,127 |
| 12:41:13 | 62.20 | 20 | 38,090 |
| 12:38:56 | 62.20 | 357 | 38,070 |
| 12:38:56 | 62.20 | 29 | 37,713 |
| 12:38:56 | 62.20 | 34 | 37,684 |
Price Extremes
| 1 week | 61.9 |  | 64.55 |
| 1 month | 61.9 | | 67.8 |
| Current year | 53.89 | | 68.51 |
| 1 year | 53.89 | | 79.09 |
| 3 years | 51.54 | | 112.91 |
| 5 years | 51.54 | | 112.91 |
| 10 years | 51.54 | | 112.91 |
Monthly variations
Annual variations
| 2026 | -2.11% | ||
| 2025 | -8.70% | ||
| 2024 | +14.26% |
- Stock Market
- Stocks
- 4016 Stock
- Quotes Middle East Pharmaceutical Industries Company
Select your edition
All financial news and data tailored to specific country editions
